Clinical Trials Sponsored by Acutus Medical

Total 56144 results

Arcutis Biotherapeutics, Inc.

Completed

Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis (DERMIS-OLE)

Chronic Plaque Psoriasis

United States, Canada, Dominican Republic
Arcutis Biotherapeutics, Inc.

Completed

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

Psoriasis | Plaque Psoriasis

United States, Canada, Dominican Republic
Arcutis Biotherapeutics, Inc.

Completed

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Atopic Dermatitis (Eczema)

United States
Arcutis Biotherapeutics, Inc.

Completed

Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Seborrheic Dermatitis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis (DERMIS-1)

Chronic Plaque Psoriasis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

Plaque Psoriasis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis (ARQ-151-201)

Plaque Psoriasis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Psoriasis

Canada, United States
Arbutus Biopharma Corporation

Completed

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Cancer | Neuroendocrine Tumors | Adrenocortical Carcinoma | ACC | NET

United States
Acerus Pharmaceuticals Corporation

Withdrawn

Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma

Asthma
Acerus Pharmaceuticals Corporation

Withdrawn

Influence of Administration Route of Testosterone on Male Fertility

Hypogonadism

Netherlands
Altus Pharmaceuticals

Completed

Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

Adult Growth Hormone Deficiency

United States
Oculus Innovative Sciences, Inc.

Completed

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Pruritus | Atopic Dermatitis

United States
Oculus Innovative Sciences, Inc.

Completed

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Foot Ulcer, Diabetic

United States
Oculus Innovative Sciences, Inc.

Unknown

A Substantial Equivalence Study of RD04723 and Predicate Device

Hypertrophic Scar | Keloid Scar

United States
Assembly Biosciences
Arbutus Biopharma Corporation

Terminated

A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection

Chronic Hepatitis B

Australia, Canada, Bulgaria, New Zealand
University of Florida
Acerus Pharmaceutical

Recruiting

Natesto Spermatogenesis Reboot

Hypogonadism, Male

United States
Acute Leukemia French Association

Completed

Multicenter Retrospective Observatory of Patients With Acute Myeloid Leukemia to Core Binding Factor (RETRO-CBF)

Acute Myeloblastic Leukemia Core Binding Factor

France
Acute Leukemia French Association

Completed

DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML (MYLOFRANCE2)

Acute Myeloid Leukemia

France
Acute Leukemia French Association

Recruiting

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML) (ALFAPPP)

Acute Myeloid Leukemia (AML)

France
University of Miami
Acerus Pharmaceuticals Corporation

Completed

A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Hypogonadism, Male

United States
University of Miami
Acerus Pharmaceuticals Corporation

Completed

Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

Hypogonadism, Male

United States
University of Utah
Acerus Pharmaceuticals Corporation

Withdrawn

Natesto Testosterone Nasal Gel for Hypogonadal Men

Sexual Dysfunction | Erectile Dysfunction

United States
Worcestershire Acute Hospitals NHS Trust

Completed

Long Term Study of 3 Radiofrequency Devices (3RF-5Years)

Varicose Veins of Lower Limb

United Kingdom
Worcestershire Acute Hospitals NHS Trust

Completed

Trial of Radiofrequency Thermo-ablation Treatments of Great Saphenous Varicose Veins (3-RF Study)

Varicose Veins

United Kingdom
International Consortium on Acute Leukemias

Unknown

Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML (ICAML2015)

Acute Myeloid Leukemia

Brazil
Pennine Acute Hospitals NHS Trust

Unknown

Study of the Use of Humidified Warmed Gas and the Effect on Post-Operative Pain in Laparoscopic Cholecystectomies

Gallstone

United Kingdom
Diwakar Davar
Aculeus Therapeutics

Completed

Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

NSCLC | Metastatic Colorectal Carcinoma | Refractory Melanoma

United States
University of Maryland, Baltimore
Arbutus Biopharma Corporation

Not yet recruiting

Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B (i-LIVER)

Chronic Hepatitis B
Acute Leukemia French Association
Versailles Hospital

Completed

A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old

Acute Myeloid Leukemia

France
Osaka Acute Coronary Insufficiency Study Group

Unknown

Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study (PRACTIC)

Acute Myocardial Infarction

Japan
Arbutus Biopharma Corporation
United States Department of Defense

Terminated

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

Ebola Virus Infection

United States
Fundacio Ictus Malaltia Vascular
Medtronic - MITG

Terminated

Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours (REVASCAT)

Acute Stroke

Spain
Arbutus Biopharma Corporation
United States Department of Defense

Terminated

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802

Ebola Virus Infection

United States
Third National Registry of Acute Coronary Syndromes

Completed

THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES (RENASICA_III)

Acute Coronary Syndromes
Lancaster University
Pennine Acute Hospitals NHS Trust

Completed

Vaccination Coverage Amongst Children/Young People Attending the PED

Vaccination/Immunisation Status

United Kingdom
French Innovative Leukemia Organisation
Acute Leukemia French Association; Group for Research in Adult Acute Lymphoblastic...

Completed

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19 (COVLA)

Acute Lymphoblastic Leukemia | SARS-CoV-2 | Acute Myeloblastic Leukemia

France
Centre Antoine Lacassagne
Acute Leukemia French Association

Not yet recruiting

A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD Relapse/Refractory (R/R) AML (AGORA-1)

AML
University of Alabama at Birmingham
Oculus Innovative Sciences, Inc.

Completed

Pressure Ulcer Healing With Microcyn

Spinal Cord Injuries | Pressure Ulcer

United States
French Innovative Leukemia Organisation
Acute Leukemia French Association

Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (OGILAR)

AML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
Oregon Health and Science University
ACUTE Innovations, LLC

Completed

Evaluation of Surgical Treatment on Pain and Disability for Chronic, Non-healing Rib Fracture

Rib Fracture

United States
Acute Leukemia French Association
Hospices Civils de Lyon

Completed

Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia
French Innovative Leukemia Organisation
Acute Leukemia French Association

Not yet recruiting

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

AML, Adult

France
French Innovative Leukemia Organisation
Acute Leukemia French Association

Completed

A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE (ELEGANCE)

Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
Pennine Acute Hospitals NHS Trust
Roche Pharma AG

Unknown

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Hepatitis C

United Kingdom
French Innovative Leukemia Organisation
Acute Leukemia French Association

Not yet recruiting

Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine (VENAZA)

AML, Adult

France
Oregon Health and Science University
ACUTE Innovations, LLC

Completed

Clinical Study of the U-Plate Fracture Repair System to Treat Rib Fractures

Flail Chest | Rib Fracture

United States
Acute Leukemia French Association
Assistance Publique - Hôpitaux de Paris

Terminated

A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.

Acute Myeloid Leukemia

France
Acute Leukemia French Association
Assistance Publique - Hôpitaux de Paris

Withdrawn

ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML) (ALFA-0703)

Acute Myeloid Leukemia

France

3

Subscribe